<DOC>
	<DOCNO>NCT01228149</DOCNO>
	<brief_summary>The common cause post-trabeculectomy filtration failure postoperative scarring . Long-term preoperative treatment local antiglaucoma agent contain preservative increase risk post-operative scar filtration bleb . Therefore many surgeon prepare patient plan trabeculectomy discontinue local antiglaucoma drug , control IOP oral acetazolamide , treat eye local steroid . Preservative-free COSOPT-S® eye drop b.i.d provide possibility reduce IOP preoperatively aim avoid postoperative excessive scar known adverse effect oral acetazolamide achieve comparable IOP reduction long-term outcome . This study investigate comparability ( non-inferiority ) medical benefit two different IOP lower pharmaceutical intervention prior trabeculectomy compare COSOPT-S® bid oral acetazolamide plus dexamethasone .</brief_summary>
	<brief_title>COSOPT-S® Treatment Versus Acetazolamide Before Trabeculectomy</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<criteria>Male female patient age 18 year old Caucasian A clinical diagnosis open angle glaucoma , pseudoexfoliation pigment dispersion glaucoma , ocular hypertension one eye Planned trabeculectomy Previous treatment antiglaucoma agent contain preservative least one month Best correct visual acuity 20/800 good study eye Secondary glaucoma except pseudoexfoliation glaucoma pigmentary glaucoma Current ocular infection , i.e . conjunctivitis keratitis Any abnormality prevent reliable applanation tonometry Intraocular surgery laser treatment within past three month History surgery involve conjunctiva History cataract surgery sclerocorneal approach Subject allergic sulfonamide Reactive airway disease , include bronchial asthma history bronchial asthma , severe chronic obstructive pulmonary disease Sinus bradycardia , second third degree atrioventricular block , overt cardiac failure , cardiogenic shock Severe renal dysfunction ( CrCl &lt; 30 ml/min ) hyperchloraemic acidosis Depressed blood level sodium / potassium Marked kidney liver disease dysfunction , gout , suprarenal gland failure , hypercalciuria nephrocalcinosis History hypersensitivity investigational medicinal product drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>trabeculectomy</keyword>
	<keyword>intraocular pressure</keyword>
</DOC>